Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT05471843 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05471843
Sponsor: BeiGene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma (MCL)Relapsed Mantle Cell Lymphoma

Start date: 2022-09-05
Primary completion: 2025-07-18
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.